Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.
We have implemented updates to our Transparency and Privacy Policy.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected] Learn more

HA-VHL C162F-pRc/CMV Citations (2)

Plasmid Article: Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cul2.
Lonergan KM, Iliopoulos O, Ohh M, Kamura T, Conaway RC, Conaway JW, Kaelin WG Mol Cell Biol. 1998 Feb . 18(2):732-41.
PubMed

Articles Citing HA-VHL C162F-pRc/CMV

Articles
ERK5/BMK1 is a novel target of the tumor suppressor VHL: implication in clear cell renal carcinoma. Arias-Gonzalez L, Moreno-Gimeno I, del Campo AR, Serrano-Oviedo L, Valero ML, Esparis-Ogando A, de la Cruz-Morcillo MA, Melgar-Rojas P, Garcia-Cano J, Cimas FJ, Hidalgo MJ, Prado A, Callejas-Valera JL, Nam-Cha SH, Gimenez-Bachs JM, Salinas-Sanchez AS, Pandiella A, del Peso L, Sanchez-Prieto R. Neoplasia. 2013 Jun;15(6):649-59. PubMed
Protein 4.1R Influences Myogenin Protein Stability and Skeletal Muscle Differentiation. Huang SC, Zhou A, Nguyen DT, Zhang HS, Benz EJ Jr. J Biol Chem. 2016 Dec 2;291(49):25591-25607. Epub 2016 Oct 25. PubMed

If you have published an article using this plasmid, please email us at [email protected] to have your article added to this page.